CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,800,000,000 | -5.4% | 30,000,000 | 0.0% | 0.38% | +22.5% |
| Q2 2022 | $20,923,000,000 | +2.6% | 30,000,000 | 0.0% | 0.31% | +56.6% |
| Q4 2021 | $20,400,000,000 | -2.6% | 30,000,000 | +3.4% | 0.20% | +19.5% |
| Q3 2021 | $20,952,000,000 | -3.7% | 29,000,000 | 0.0% | 0.16% | -15.5% |
| Q2 2021 | $21,750,000,000 | 0.0% | 29,000,000 | 0.0% | 0.19% | -38.0% |
| Q1 2021 | $21,750,000,000 | +8.2% | 29,000,000 | 0.0% | 0.31% | -23.8% |
| Q4 2020 | $20,108,000,000 | +0.5% | 29,000,000 | 0.0% | 0.41% | -19.1% |
| Q3 2020 | $20,004,000,000 | +12.0% | 29,000,000 | -3.3% | 0.51% | +28.9% |
| Q2 2020 | $17,858,000,000 | -5.4% | 30,000,000 | 0.0% | 0.39% | +1.3% |
| Q1 2020 | $18,871,000,000 | -6.1% | 30,000,000 | -6.2% | 0.39% | -31.6% |
| Q4 2019 | $20,106,000,000 | +49.3% | 32,000,000 | +6.7% | 0.57% | +51.7% |
| Q3 2019 | $13,469,000,000 | -27.5% | 30,000,000 | 0.0% | 0.38% | +4.2% |
| Q2 2019 | $18,578,000,000 | +426.9% | 30,000,000 | +500.0% | 0.36% | +183.5% |
| Q4 2018 | $3,526,000,000 | – | 5,000,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|